Kathryn C. Zoon - 29 May 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
29 May 2024
Transactions value $
-$8,436
Form type
4
Filing time
31 May 2024, 15:02:45 UTC
Previous filing
28 May 2024
Next filing
06 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale -$8.44K -1.83K -2.76% $4.61 64.5K 29 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a grandfathered trading plan adopted by Ms. Zoon on June 15, 2022.